secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pulmonx Corp (LUNG)
CIK:        0001127537
Form:       8-K
Filed at:   2021-08-02T23:59:59+00:00
Accession:  0001127537-21-000033
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Pulmonx appoints Alissa Hsu Lynch and Tiffany Sullivan as Class I directors
---------------------------------------------------------------------------

- Appointments effective July 29, 2021; directors serve until 2024 annual meeting.
- Lynch joins Audit Committee; Sullivan joins Nominating and Corporate Governance Committee.
- Each receives $40k annual cash fee, initial RSU grant of $180k vesting over 3 years, plus annual equity grants.
- Each enters standard indemnification agreement with Pulmonx.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1127537/000112753721000033/0001127537-21-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1127537/000112753721000033/lung-20210729.htm
  HTML page:      https://secwatch.observer/filing/0001127537-21-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer